Загрузка...
Inhibiting Arginine Methylation as a Tool to Investigate Cross-Talk with Methylation and Acetylation Post-Translational Modifications in a Glioblastoma Cell Line
Glioblastomas (GBM) are the most common grade 4 brain tumours; patients have very poor prognosis with an average survival of 15 months after diagnosis. Novel research lines have begun to explore aberrant protein arginine methylation (ArgMe) as a possible therapeutic target in GBM and ArgMe inhibitor...
Сохранить в:
| Опубликовано в: : | Proteomes |
|---|---|
| Главные авторы: | , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
MDPI
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6313862/ https://ncbi.nlm.nih.gov/pubmed/30347783 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/proteomes6040044 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|